Table III.
Univariate and multivariate Cox regression analysis of clinicopathological data correlated with overall survival in hepatocellular carcinoma patients.
| Univariate analysis | Multivariate analysis (n=264) | ||||
|---|---|---|---|---|---|
| Factor | n | HR (95% CI) | P-value | HR (95% CI) | P-value |
| Age, years (>60/≤60) | 370 | 1.212 (0.854–1.720) | 0.281 | 1.420 (0.875–2.303) | 0.156 |
| Gender (male/female) | 370 | 1.225 (0.859–1.745) | 0.262 | 1.348 (0.838–2.167) | 0.218 |
| TNM stage (1/2-4) | 346 | 1.661 (1.355–2.036) | <0.001 | 1.348 (0.846–2.148) | 0.209 |
| AFP level (high/low) | 277 | 1.855 (1.159–2.970) | 0.010 | 1.528 (0.936–2.495) | 0.090 |
| CTAG2 expression (high/low) | 370 | 1.457 (1.028–2.066) | 0.035 | 1.440 (0.893–2.324) | 0.135 |
HR, hazard ratio; 95% CI, 95% confidence interval; AFP, α-fetoprotein; CTAG2, cancer/testis antigen 2.